ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420601 | Rec_0433259 | Unnamed |
LLLLHKHGHGHGKHKNKGKK |
synthetic construct [Synthetic] |
Hemolytic |
erythrocytes |
3.006±0.082 % | Hemolysis |
- | US 8227406 B2 |
YES |
| 420602 | Rec_0433260 | Longicalycinin A cyclic analogue 6 |
VYPIA |
synthetic construct [Synthetic] |
Anticancer, Cytotoxic |
HT-29 |
27.61 % | MTT assay (cell death at 100 μg/mL, 24 h) |
31747558 | - |
YES |
| 420603 | Rec_0433261 | Longicalycinin A cyclic analogue 6 |
VYPIA |
synthetic construct [Synthetic] |
Anticancer, Cytotoxic |
HepG-2 |
51.79 % | MTT assay (cell death at 100 μg/mL, 24 h) |
31747558 | - |
YES |
| 420604 | Rec_0433262 | [C2A, C9A, C20S, C27S]GeXIVA |
TARSSGRYARSPYDRRRRYSRRITDASV |
synthetic construct [Synthetic] |
α9α10 nAChR antagonist, Receptor antagonist, Analgesic |
human α9α10 nicotinic acetylcholine receptor |
33 (25-42) nM | IC50 |
31986036 | CN112010972A |
YES |
| 420605 | Rec_0433263 | Mesothelin P547 (547-556) |
KLLGPHVEGL |
Homo sapiens [Animal] |
T-cell epitope, HLA-A2 binding, Anticancer |
HLA-A2 molecules (T2 cells) |
407 MFI | T2 cell HLA-A2 binding assay |
16144939 | - |
YES |
| 420606 | Rec_0433264 | Unnamed |
GLFSILKREIKRTFSMFYRWL |
synthetic construct [Synthetic] |
Antimicrobial |
Escherichia coli TOP10 |
99 % | growth inhibition assay (0.1% arabinose induction) |
- | US 2007/0259087 A1 |
YES |
| 420607 | Rec_0433265 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa KCTC 1637 |
8 μM | MIC |
19285481 | - |
YES |
| 420608 | Rec_0433266 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Salmonella typhimurium KCTC 1926 |
4 μM | MIC |
19285481 | - |
YES |
| 420609 | Rec_0433267 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Bacillus subtilis KCTC 3068 |
4 μM | MIC |
19285481 | - |
YES |
| 420610 | Rec_0433268 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Staphylococcus epidermidis KCTC 1917 |
2 μM | MIC |
19285481 | - |
YES |
| 420611 | Rec_0433269 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Staphylococcus aureus KCTC 1621 |
8 μM | MIC |
19285481 | - |
YES |
| 420612 | Rec_0433270 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
methicillin-resistant Staphylococcus aureus CCARM 3001 |
8 μM | MIC |
19285481 | - |
YES |
| 420613 | Rec_0433271 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
methicillin-resistant Staphylococcus aureus CCARM 3543 |
4 μM | MIC |
19285481 | - |
YES |
| 420614 | Rec_0433272 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
multidrug-resistant Pseudomonas aeruginosa CCARM 2095 |
16 μM | MIC |
19285481 | - |
YES |
| 420615 | Rec_0433273 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
multidrug-resistant Pseudomonas aeruginosa CCARM 2109 |
16 μM | MIC |
19285481 | - |
YES |
| 420616 | Rec_0433274 | R8W3 |
RRWRRWRRWRR |
synthetic construct [Synthetic] |
Hemolytic |
human erythrocytes |
>400 μM | MHC (5% hemolysis endpoint) |
19285481 | - |
YES |
| 420617 | Rec_0433275 | Cupiennin-1b |
GFGSLFKFLAKKVAKTVAKQAAKQGAKYIANKQME |
Cupiennius salei [Animal] |
Insecticidal, Toxic |
Drosophila melanogaster |
4.7 pmol/mg fly | LD50 (24 h injection bioassay) |
11792701 | - |
YES |
| 420618 | Rec_0433276 | Cupiennin-1b |
GFGSLFKFLAKKVAKTVAKQAAKQGAKYIANKQME |
Cupiennius salei [Animal] |
Hemolytic, Cytolytic |
human erythrocytes |
15 % | Hemolysis (8 μM peptide; 1 h at 37°C) |
11792701 | - |
YES |
| 420619 | Rec_0433277 | YPTPYDI tumor-homing peptide |
YPTPYDI |
synthetic construct [Synthetic] |
Tumor homing, Drug delivery vehicle |
human esophageal cancer xenograft tumor vasculature |
- | In vivo M13 phage-display homing assay |
- | US 2010/0233161 A1 |
YES |
| 420620 | Rec_0433278 | hoki frame antioxidant peptide |
ESTVPERTHPACPDFN |
Johnius belengerii [Animal] |
Antioxidant, Free-radical scavenging |
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical |
41.37 μM | IC50 (electron spin resonance radical-scavenging assay) |
16563720 | - |
YES |